[ATX] YoY Annual Result on 31-Mar-2017 [#FY]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
30-Mar-2017
Financial Year
2017
Quarter
31-Mar-2017 [#FY]
Profit Trend
YoY- -43.15%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Annual Result
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
Revenue 34 50 580 1,798 2,263 30 0 -
PBT -2,254 -1,920 -4,298 -8,874 -7,206 -5,237 -4,495 -10.85%
Tax -34 -50 -0 -1,798 -2,263 -162 521 -
NP -2,219 -1,870 -4,298 -7,076 -4,943 -5,237 -4,495 -11.08%
Tax Rate - - - - - - - -
Total Cost 2,254 1,920 4,878 8,874 7,206 5,267 4,495 -10.85%
Ratio Analysis
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
NP Margin -6,484.57 -3,704.79 -740.59 -393.54 -218.40 -17,278.70 0.00 -
Per Share
31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 CAGR
EPS -0.04 -0.04 -0.17 -0.30 -0.24 -0.27 -0.34 -29.97%
EPS Diluted -0.04 -0.04 -0.17 -0.30 -0.24 -0.27 -0.34 -29.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.